Market & Economic Perspectives
Will the Biogen Drug Approval Be a Boon for Biotech?
The new Alzheimer's drug from Biogen may be a boon for biotech, but investors have reasons to be wary.
Market & Economic Perspectives
06.18.21Estimated Reading Time: 5 Minutes
Banks Back on the Road to Recovery
As we begin to put the COVID crisis in the rearview mirror, could a new dawn be breaking for banks?
Market & Economic Perspectives05.21.21Estimated Reading Time: 6 Minutes
Is Inflation as Scary as It Seems?
Is inflation as scary as it seems? Let's dig into the numbers to find out.
Market & Economic Perspectives
05.19.21Estimated Reading Time: 5 Minutes
5 Investing Themes for the Post-Pandemic World
By paying attention to these five investing themes for the post-pandemic world, you can help position portfolios for whatever lies ahead.
Market & Economic Perspectives04.14.21Estimated Reading Time: 5 Minutes
A Sober Outlook for Emerging Market Debt
Do the potentially high yields of emerging market debt outweigh the risks for investors?
Market & Economic Perspectives03.25.21Estimated Reading Time: 7 Minutes
Optimistic Outlook for Emerging Markets in 2021?
Where will emerging markets go next? Commonwealth's Anu Gaggar says there is much to like about their fundamental outlook.
Market & Economic Perspectives03.18.21Estimated Reading Time: 6 Minutes
